Increasing visibility with a proactive supply chain

Document

Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.

What is on this page?

Click to jump to a specific section below.

Introduction

Our whole story starts here

Mission and vision

Logipharma report

The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data.

In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table.

CEO Niclas Ohlsson, share TSS's view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.

Highlights:

  • Recommendations on Implementing a Real-Time Monitoring Solution
  • A Glimpse into the Future of Pharma Logistics
  • The Evolving Digital Landscape
  • Increasing Visibility
  • Utilizing Real-Time Data

‍

Complete the form below to download a copy of the report.

‍


You may also be interested in

A headshot of Johanna Eriksson, Chief Product Officer at TSS.

Meet Johanna Eriksson, Chief Product Officer at TSS

We are very excited to continue building an industry-leading team at TSS and so are delighted to officially welcome our new Chief Product Officer (CPO), Johanna Eriksson. Johanna has worked in the pharmaceutical industry for a number of years; she has lots of experience in collaborating with companies, agencies, and other stakeholders to create great products and solutions to make sure drugs are distributed safely for patients.
Read moreDownload Whitepaper
A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read moreDownload Whitepaper

Could automating temperature excursion management hold the key to improving clinical supply processes?

There are a few key reasons why many sponsors are starting to ask whether current clinical supply processes are efficient enough.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
A view of Earth from space at night, representing the global reach of TSS's new BLE technology for temperature monitoring.

On-demand webinar: Introducing BLE technology for temperature monitoring

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.